ClinicalTrials.Veeva

Menu

Crystalloid vs Colloid for Hemodynamics During Anesthesia Induction in TAVR Patients (CHAIN-T)

A

Air Force Military Medical University of People's Liberation Army

Status

Not yet enrolling

Conditions

Transcatheter Aortic Valve Replacement
Anesthesia Induction
Hemodynamic Stability

Treatments

Drug: Hydroxyethyl starch 130/0.4
Drug: Lactate Ringer's Solution

Study type

Interventional

Funder types

Other

Identifiers

NCT07329660
XJH-A-20250824

Details and patient eligibility

About

The purpose of this study is to evaluate whether the administration of 5 ml/kg of colloid solution prior to anesthesia induction, compared with 5 ml/kg of lactated Ringer's solution, can reduce hemodynamic fluctuations during the induction period (defined as the first 15 minutes after induction) in patients undergoing Transcatheter Aortic Valve Replacement (TAVR).

Enrollment

116 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years;
  • Patients scheduled to undergo elective TAVR under general anesthesia;

Exclusion criteria

  • Allergy to hydroxyethyl starch, its components, and/or sodium lactate Ringer's solution, or a history of colloidal allergy;
  • Severe cardiac dysfunction (ejection fraction[EF] < 35%);
  • Severe renal dysfunction (creatinine > 132 μg/L and/or requiring renal replacement therapy);
  • Morbid obesity (body mass index[BMI] > 37.5 kg/m² or > 32.5 kg/m² with metabolic diseases);
  • Severe hepatic dysfunction ;
  • Severe electrolyte disturbances ;
  • Patients with preoperative intracranial hypertension requiring dehydration therapy;
  • Expected postoperative hospital stay < 24 hours;
  • Patients scheduled for multiple surgeries during this hospitalization.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

116 participants in 2 patient groups

Colloid
Experimental group
Description:
5 ml/kg of hydroxyethyl starch 130/0.4 electrolyte injection.
Treatment:
Drug: Hydroxyethyl starch 130/0.4
Crystalloid
Active Comparator group
Description:
5 ml/kg of sodium lactate Ringer's solution is administered before anesthesia induction.
Treatment:
Drug: Lactate Ringer's Solution

Trial contacts and locations

0

Loading...

Central trial contact

Zhihong Lu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems